Literature DB >> 19124816

Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia.

Mario Venditti1, Marco Falcone, Salvatore Corrao, Giuseppe Licata, Pietro Serra.   

Abstract

BACKGROUND: Traditionally, pneumonia has been classified as either community- or hospital-acquired. Although only limited data are available, health care-associated pneumonia has been recently proposed as a new category of respiratory infection. "Health care-associated pneumonia" refers to pneumonia in patients who have recently been hospitalized, had hemodialysis, or received intravenous chemotherapy or reside in a nursing home or long-term care facility.
OBJECTIVE: To ascertain the epidemiology and outcome of community-acquired, health care-associated, and hospital-acquired pneumonia in adults hospitalized in internal medicine wards.
DESIGN: Multicenter, prospective observational study.
SETTING: 55 hospitals in Italy comprising 1941 beds. PATIENTS: 362 patients hospitalized with pneumonia during two 1-week surveillance periods. MEASUREMENTS: Cases of radiologically and clinically assessed pneumonia were classified as community-acquired, health care-associated, or hospital-acquired and rates were compared.
RESULTS: Of the 362 patients, 61.6% had community-acquired pneumonia, 24.9% had health care-associated pneumonia, and 13.5% had hospital-acquired pneumonia. Patients with health care-associated pneumonia had higher mean Sequential Organ Failure Assessment scores than did those with community-acquired pneumonia (3.0 vs. 2.0), were more frequently malnourished (11.1% vs. 4.5%, and had more frequent bilateral (34.4% vs. 19.7%) and multilobar (27.8% vs. 21.5%) involvement on a chest radiograph. Patients with health care-associated pneumonia also had higher fatality rates (17.8% [CI, 10.6% to 24.9%] vs. 6.7% [CI, 2.9% to 10.5%]) and longer mean hospital stay (18.7 days [CI, 15.9 to 21.5 days] vs. 14.7 days [CI, 13.4 to 15.9 days]). Logistic regression analysis revealed that depression of consciousness (odds ratio [OR], 3.2 [CI, 1.06 to 9.8]), leukopenia (OR, 6.2 [CI, 1.01 to 37.6]), and receipt of empirical antibiotic therapy not recommended by international guidelines (OR, 6.4 [CI, 2.3 to 17.6]) were independently associated with increased intrahospital mortality. LIMITATIONS: The number of patients with health care-associated pneumonia was relatively small. Microbiological investigations were not always homogeneous. The study included only patients with pneumonia that required hospitalization; results may not apply to patients treated as outpatients.
CONCLUSION: Health care-associated pneumonia should be considered a distinct subset of pneumonia associated with more severe disease, longer hospital stay, and higher mortality rates. Physicians should differentiate between patients with health care-associated pneumonia and those with community-acquired pneumonia and provide more appropriate initial antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19124816     DOI: 10.7326/0003-4819-150-1-200901060-00005

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  79 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

2.  A Hypothesis-Generating Study of the Combination of Aspirin plus Macrolides in Patients with Severe Community-Acquired Pneumonia.

Authors:  Marco Falcone; Alessandro Russo; Yuichiro Shindo; Alessio Farcomeni; Filippo Pieralli; Roberto Cangemi; Jinliang Liu; Jingyan Xia; Junya Okumura; Masahiro Sano; Christopher Jones; Vieri Vannucchi; Massimo Mancone; Scott Micek; Feng Xu; Francesco Violi; Marin Kollef
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

3.  Severe hospital-acquired pneumonia: a review for clinicians.

Authors:  John Dallas; Marin Kollef
Journal:  Curr Infect Dis Rep       Date:  2009-09       Impact factor: 3.725

4.  Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia.

Authors:  Marco Falcone; Salvatore Corrao; Mario Venditti; Pietro Serra; Giuseppe Licata
Journal:  Intern Emerg Med       Date:  2011-01-20       Impact factor: 3.397

5.  Emerging problems regarding severity assessment and treatment strategies for patients with pneumonia: controversies surrounding the HCAP concept.

Authors:  Yuichiro Shindo; Yoshinori Hasegawa
Journal:  Intern Emerg Med       Date:  2011-05-18       Impact factor: 3.397

6.  Delirium is a predictor of in-hospital mortality in elderly patients with community acquired pneumonia.

Authors:  Filippo Pieralli; Vieri Vannucchi; Antonio Mancini; Maddalena Grazzini; Giulia Paolacci; Alessandro Morettini; Carlo Nozzoli
Journal:  Intern Emerg Med       Date:  2013-09-19       Impact factor: 3.397

Review 7.  Long-term prognosis in community-acquired pneumonia.

Authors:  Marcos I Restrepo; Paola Faverio; Antonio Anzueto
Journal:  Curr Opin Infect Dis       Date:  2013-04       Impact factor: 4.915

8.  Evaluation of hospital inpatient complications: a planning approach.

Authors:  Ronald J Lagoe; Gert P Westert
Journal:  BMC Health Serv Res       Date:  2010-07-09       Impact factor: 2.655

9.  Influence of socioeconomic status on community-acquired pneumonia outcomes in elderly patients requiring hospitalization: a multicenter observational study.

Authors:  Conchita Izquierdo; Manuel Oviedo; Laura Ruiz; Xavier Sintes; Isabel Vera; Manel Nebot; Jose-María Bayas; Jordi Carratalà; Wenceslao Varona; Dolores Sousa; Jose-Miguel Celorrio; Luis Salleras; Angela Domínguez
Journal:  BMC Public Health       Date:  2010-07-15       Impact factor: 3.295

10.  Comparison of severe healthcare-associated pneumonia with severe community-acquired pneumonia.

Authors:  Byeong-Ho Jeong; Eun Ju Jeon; Hongseok Yoo; Won-Jung Koh; Gee Young Suh; Man Pyo Chung; O Jung Kwon; Kyeongman Jeon
Journal:  Lung       Date:  2013-12-01       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.